Log in using your username and password
Registration is Now Required for Free Access to CCJM Content
Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.
If you are using a mobile device, click on the settings icon to access the Register link.
In this issue
The role of SGLT-2 inhibitors in managing type 2 diabetes
Jump to section
- Article
- ABSTRACT
- SODIUM-GLUCOSE COTRANSPORTER-2
- EFFECT ON GLYCEMIC CONTROL
- EFFECT ON CARDIOVASCULAR OUTCOMES
- POSSIBLE MECHANISMS OF CARDIOVASCULAR BENEFIT
- EFFECT ON RENAL OUTCOMES
- MECHANISM OF RENAL PROTECTION
- EFFECT ON METABOLIC OUTCOMES
- STUDIES IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
- ADVERSE EFFECTS OF SGLT-2 INHIBITORS
- REVIEW OF THE GUIDELINES
- FUTURE DIRECTIONS
- DISCLOSURES
- REFERENCES
- Figures & Data
- Info & Metrics